<DOC>
	<DOCNO>NCT00936871</DOCNO>
	<brief_summary>This study design investigate effect lersivirine QT/QTc interval order help establish safety profile lersivirine .</brief_summary>
	<brief_title>The Effect Of Lersivirine ( UK-453,061 ) On Qt Intervals In Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Healthy male and/or female subject age 18 55 year , inclusive , ( Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , normal 12lead ECG clinical laboratory test ) History risk factor QT prolongation torsades de pointes ( eg , organic heart disease , congestive heart failure , hypokalemia , hypomagnesemia , congenital long QT syndrome , myocardial ischemia infarction ) . Use tobacco nicotinecontaining product excess equivalent 5 cigarette per day Use prescription nonprescription drug , vitamin dietary supplement within 7 day 5 halflives ( whichever longer ) prior first dose trial medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>lersivirine QT QTc ECG HIV NNRTI</keyword>
</DOC>